All News

President Trump today called for "tougher negotiation, more competition, and much lower prices at the pharmacy counter," in a statement on lowering drug prices.

Officials with the FDA have approved fingolimod (Gilenya, Novartis) for the treatment of relapsing multiple sclerosis (MS) in pediatric patients aged 10 years and older.

An HIV primary care program is working to reduce the number of new HIV diagnoses and increase viral suppression rates in Long Island and Queens.

A new division at Amazon spotlights how they are looking to turn their home health assistant into a health care tool.

If you’re like most pharmacy graduates with a significant amount of student loans, it’s time to seriously consider whether refinancing is right for you.

Simple tweaks in your routine can have a huge impact on your productivity.

A recent study looked at the benefits of digital health by tracking the use of SABAs to correlate hotspots of pollutants in the community. Using this data can lead to multiple policy changes for public health.

Pharmacists can find a job anywhere in the world.

Happy Mother's Day! Pharmacists, and Moms are alike in so many ways!

In entering into an arrangement with a physician in a rural area, the pharmacy needs to focus on the Stark rural provider exception.

Officials with the FDA have approved fingolimod (Gilenya, Novartis) for the treatment of relapsing multiple sclerosis in pediatric patients aged 10 years and older, making it the first FDA-approved drug to treat MS in this population.

Searching for jobs is one thing. Keeping your prospects organized is another.

Fingolimod (Gilenya, Novartis) is the first FDA-approved treatment to treat multiple sclerosis in pediatric patients.

President Trump today called for "tougher negotiation, more competition, and much lower prices at the pharmacy counter," in a statement on lowering drug prices.

The President also noted he has directed officials to take actions to end what he termed "global freeloading," which he explained as lowered prices on drugs in other countries compared with the United States, where much of the investment funds for medical research originate.

Winners in the 12 categories include manufacturers, wholesalers, entrepreneurs, CEOs and pharmacy schools.

Top news of the day from across the health care landscape.

Top news of the week from The American Journal of Pharmacy Benefits.

Top news of the day from across the health care landscape.

The recommendation means more men could be screened, now that the recommendation has been upgraded from its existing D recommendation to a grade C recommendation.